Increased angiogenesis and improved left ventricular function after transplantation of myoblasts lacking the MyoD gene into infarcted myocardium

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Nakamura, Yasuhiro ^a,b   Asakura, Yoko ^a   Piras, Bryan A ^a   Hirai, Hiroyuki ^a   Tastad, Christopher T ^a   Verma, Mayank ^a   Christ, Amanda J ^a   Zhang, Jianyi ^a   Yamazaki, Takanori ^b   Yoshiyama, Minoru ^b   Asakura, Atsushi ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MYOD PROTEIN; PLACENTAL GROWTH FACTOR; STROMAL CELL DERIVED FACTOR 1;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE; GENE ACTIVITY; GENE FUNCTION; GENE OVEREXPRESSION; GENE SEQUENCE; GENE SILENCING; GENETIC REGULATION; HEART EJECTION FRACTION; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HYPOXIA; MOUSE; MYOBLAST; MYOD GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; STEM CELL TRANSPLANTATION;

ANIMALS; CELL DIFFERENTIATION; CELL HYPOXIA; CELL PROLIFERATION; CELL SURVIVAL; CHEMOKINE CXCL12; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; MICE; MICE, INBRED BALB C; MUSCLE, SKELETAL; MYOBLASTS; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOD PROTEIN; NEOVASCULARIZATION, PHYSIOLOGIC; PREGNANCY PROTEINS; STEM CELL TRANSPLANTATION; VENTRICULAR DYSFUNCTION, LEFT;

MURINAE;

EID: 84864701343     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041736     Document Type: Article

References (80)

1. Masuda H, Asahara T, (2003) Post-natal endothelial progenitor cells for neovascularization in tissue regeneration. Cardiovasc Res 58: 390-398.
2. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD, (2002) Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105: 93-98.
3. Pelacho B, Nakamura Y, Zhang J, Ross J, Heremans Y, et al. (2007) Multipotent adult progenitor cell transplantation increases vascularity and improves left ventricular function after myocardial infarction. J Tissue Eng Regen Med 1: 51-59.
4. Kolossov E, Bostani T, Roell W, Breitbach M, Pillekamp F, et al. (2006) Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J Exp Med 203: 2315-2327.
5. Shimoji K, Yuasa S, Onizuka T, Hattori F, Tanaka T, et al. (2010) G-CSF promotes the proliferation of developing cardiomyocytes in vivo and in derivation from ESCs and iPSCs. Cell Stem Cell 6: 227-237.
6. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, et al. (2003) Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114: 763-776.
7. Oh H, Bradfute SB, Gallardo TD, Nakamura T, Gaussin V, et al. (2003) Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA 100: 12313-12318.
8. Tomita Y, Matsumura K, Wakamatsu Y, Matsuzaki Y, Shibuya I, et al. (2005) Cardiac neural crest cells contribute to the dormant multipotent stem cell in the mammalian heart. J Cell Biol 170: 1135-1146.
9. Galvez BG, Sampaolesi M, Barbuti A, Crespi A, Covarello D, et al. (2008) Cardiac mesoangioblasts are committed, self-renewable progenitors, associated with small vessels of juvenile mouse ventricle. Cell Death Differ 15: 1417-1428.
10. Tonlorenzi R, Dellavalle A, Schnapp E, Cossu G, Sampaolesi M, (2007) Isolation and characterization of mesoangioblasts from mouse, dog, and human tissues. Curr Protoc Stem Cell Biol Chapter 2: Unit 2B 1.
11. Oshima H, Payne TR, Urish KL, Sakai T, Ling Y, et al. (2005) Differential myocardial infarct repair with muscle stem cells compared to myoblasts. Mol Ther 12: 1130-1141.
12. Formigli L, Zecchi-Orlandini S, Meacci E, Bani D, (2010) Skeletal Myoblasts for Heart Regeneration and Repair: State of the Art and Perspectives on the Mechanisms for Functional Cardiac Benefits. Curr Pharm Des 16: 915-928.
13. Hagege AA, Carrion C, Menasche P, Vilquin JT, Duboc D, et al. (2003) Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet 361: 491-492.
14. Menasche P, Hagege AA, Scorsin M, Pouzet B, Desnos M, et al. (2001) Myoblast transplantation for heart failure. Lancet 357: 279-280.
15. Taylor DA, Atkins BZ, Hungspreugs P, Jones TR, Reedy MC, et al. (1998) Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 4: 929-933.
16. Menasche P, Hagege AA, Vilquin JT, Desnos M, Abergel E, et al. (2003) Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41: 1078-1083.
17. Hagege AA, Marolleau JP, Vilquin JT, Alheritiere A, Peyrard S, et al. (2006) Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients. Circulation 114: I108-113.
18. Chedrawy EG, Wang JS, Nguyen DM, Shum-Tim D, Chiu RC, (2002) Incorporation and integration of implanted myogenic and stem cells into native myocardial fibers: anatomic basis for functional improvements. J Thorac Cardiovasc Surg 124: 584-590.
19. Reinecke H, Poppa V, Murry CE, (2002) Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J Mol Cell Cardiol 34: 241-249.
20. Smits PC, van Geuns RJ, Poldermans D, Bountioukos M, Onderwater EE, et al. (2003) Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J Am Coll Cardiol 42: 2063-2069.
21. Fujita J, Mori M, Kawada H, Ieda Y, Tsuma M, et al. (2007) Administration of granulocyte colony-stimulating factor after myocardial infarction enhances the recruitment of hematopoietic stem cell-derived myofibroblasts and contributes to cardiac repair. Stem Cells 25: 2750-2759.
22. Caplan AI, Dennis JE, (2006) Mesenchymal stem cells as trophic mediators. J Cell Biochem 98: 1076-1084.
23. Shintani Y, Fukushima S, Varela-Carver A, Lee J, Coppen SR, et al. (2009) Donor cell-type specific paracrine effects of cell transplantation for post-infarction heart failure. J Mol Cell Cardiol 47: 288-295.
24. Okada M, Payne TR, Zheng B, Oshima H, Momoi N, et al. (2008) Myogenic endothelial cells purified from human skeletal muscle improve cardiac function after transplantation into infarcted myocardium. J Am Coll Cardiol 52: 1869-1880.
25. Seale P, Rudnicki MA, (2000) A new look at the origin, function, and "stem-cell" status of muscle satellite cells. Dev Biol 218: 115-124.
26. Molkentin JD, Olson EN, (1996) Defining the regulatory networks for muscle development. Curr Opin Genet Dev 6: 445-453.
27. Megeney LA, Kablar B, Garrett K, Anderson JE, Rudnicki MA, (1996) MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes Dev 10: 1173-1183.
28. Sabourin LA, Girgis-Gabardo A, Seale P, Asakura A, Rudnicki MA, (1999) Reduced differentiation potential of primary MyoD-/- myogenic cells derived from adult skeletal muscle. J Cell Biol 144: 631-643.
29. Asakura A, Hirai H, Kablar B, Morita S, Ishibashi J, et al. (2007) Increased survival of muscle stem cells lacking the MyoD gene after transplantation into regenerating skeletal muscle. Proc Natl Acad Sci USA 104: 16552-16557.
30. Hirai H, Verma M, Watanabe S, Tastad C, Asakura Y, et al. (2010) MyoD regulates apoptosis of myoblasts through microRNA-mediated down-regulation of Pax3. J Cell Biol 191: 347-365.
31. Watanabe S, Hirai H, Asakura Y, Tastad C, Verma M, et al. (2011) MyoD gene suppression by Oct4 is required for reprogramming in myoblasts to produce induced pluripotent stem cells. Stem Cells 29: 505-516.
32. Suzuki K, Murtuza B, Beauchamp JR, Smolenski RT, Varela-Carver A, et al. (2004) Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart. Faseb J 18: 1153-1155.
33. Pfeffer MA, E B, (1990) Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81: 1161-1172.
34. Cizkova D, Soukup T, Mokry J, (2009) Nestin expression reflects formation, revascularization and reinnervation of new myofibers in regenerating rat hind limb skeletal muscles. Cells Tissues Organs 189: 338-347.
35. Day K, Shefer G, Richardson JB, Enikolopov G, Yablonka-Reuveni Z, (2007) Nestin-GFP reporter expression defines the quiescent state of skeletal muscle satellite cells. Dev Biol 304: 246-259.
36. Zaglia T, Dedja A, Candiotto C, Cozzi E, Schiaffino S, et al. (2009) Cardiac interstitial cells express GATA4 and control dedifferentiation and cell cycle re-entry of adult cardiomyocytes. J Mol Cell Cardiol 46: 653-662.
37. Stievano L, Piovan E, Amadori A, (2004) C and CX3C chemokines: cell sources and physiopathological implications. Crit Rev Immunol 24: 205-228.
38. auf dem Keller U, Krampert M, Kumin A, Braun S, Werner S, (2004) Keratinocyte growth factor: effects on keratinocytes and mechanisms of action. Eur J Cell Biol 83: 607-612.
39. Greenberg ME, Xu B, Lu B, Hempstead BL, (2009) New insights in the biology of BDNF synthesis and release: implications in CNS function. J Neurosci 29: 12764-12767.
40. Möhle R KL, (2007) Hematopoietic growth factors for hematopoietic stem cell mobilization and expansion. Semin Hematol 44(3):193-202 44: 193-202.
41. Roskoski R Jr, (2008) VEGF receptor protein-tyrosine kinases: structure and regulation. Biochem Biophys Res Commun 375: 287-291.
42. Miller RJ, Banisadr G, Bhattacharyya BJ, (2008) CXCR4 signaling in the regulation of stem cell migration and development. J Neuroimmunol 198: 31-38.
43. Ricort JM, (2004) Insulin-like growth factor binding protein (IGFBP) signalling. Growth Horm IGF Res 14: 277-286.
44. Formigli L, Perna AM, Meacci E, Cinci L, Margheri M, et al. (2007) Paracrine effects of transplanted myoblasts and relaxin on post-infarction heart remodelling. J Cell Mol Med 11: 1087-1100.
45. Niagara MI, Haider H, Jiang S, Ashraf M, (2007) Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart. Circ Res 100: 545-555.
46. Di Carlo A, De Mori R, Martelli F, Pompilio G, Capogrossi MC, et al. (2004) Hypoxia inhibits myogenic differentiation through accelerated MyoD degradation. J Biol Chem 279: 16332-16338.
47. Fernando P, Kelly JF, Balazsi K, Slack RS, Megeney LA, (2002) Caspase 3 activity is required for skeletal muscle differentiation. Proc Natl Acad Sci USA 99: 11025-11030.
48. Xiang G, Yang Q, Wang B, Sekiya N, Mu X, et al. (2011) Lentivirus-mediated Wnt11 Gene Transfer Enhances Cardiomyogenic Differentiation of Skeletal Muscle-derived Stem Cells. Mol Ther.
49. Reinecke H, Minami E, Poppa V, Murry CE, (2004) Evidence for fusion between cardiac and skeletal muscle cells. Circ Res 94: e56-60.
50. Jain M, DerSimonian H, Brenner DA, Ngoy S, Teller P, et al. (2001) Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction. Circulation 103: 1920-1907.
51. Leobon B, Garcin I, Menasche P, Vilquin JT, Audinat E, et al. (2003) Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci USA 100: 7808-7811.
52. Murry CE, Wiseman RW, Schwartz SM, Hauschka SD, (1996) Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest 98: 2512-2523.
53. Haider HKh, Tan AC, Aziz S, Chachques JC, EK S, (2004) Myoblast transplantation for cardiac repair: a clinical perspective. Mol Ther 9: 14-23.
54. Gnecchi M, Zhang Z, Ni A, Dzau VJ, (2008) Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103: 1204-1219.
55. Pelacho B, Prosper F, (2008) Stem cells and cardiac disease: where are we going? Curr Stem Cell Res Ther 3: 265-276.
56. Perez-Ilzarbe M, Agbulut O, Pelacho B, Ciorba C, San Jose-Eneriz E, et al. (2008) Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myocardium. Eur J Heart Fail 10: 1065-1072.
57. Uemura R, Xu M, Ahmad N, Ashraf M, (2006) Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res 98: 1414-1421.
58. Yoon YS, Wecker A, Heyd L, Park JS, Tkebuchava T, et al. (2005) Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest 115: 326-338.
59. Miyahara Y, Nagaya N, Kataoka M, Yanagawa B, Tanaka K, et al. (2006) Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 12: 459-465.
60. Ohnishi S, Yanagawa B, Tanaka K, Miyahara Y, Obata H, et al. (2007) Transplantation of mesenchymal stem cells attenuates myocardial injury and dysfunction in a rat model of acute myocarditis. J Mol Cell Cardiol 42: 88-97.
61. Barcelos LS, Duplaa C, Krankel N, Graiani G, Invernici G, et al. (2009) Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling. Circ Res 104: 1095-1102.
62. Sondergaard CS, Hess DA, Maxwell DJ, Weinheimer C, Rosova I, et al. (2010) Human cord blood progenitors with high aldehyde dehydrogenase activity improve vascular density in a model of acute myocardial infarction. J Transl Med 8: 24.
63. Wang J, Zhang S, Rabinovich B, Bidaut L, Soghomonyan S, et al. (2010) Human CD34+ cells in experimental myocardial infarction: long-term survival, sustained functional improvement, and mechanism of action. Circ Res 106: 1904-1911.
64. Becker C, Lacchini S, Muotri AR, da Silva GJ, Castelli JB, et al. (2006) Skeletal muscle cells expressing VEGF induce capillary formation and reduce cardiac injury in rats. Int J Cardiol 113: 348-354.
65. Payne TR, Oshima H, Okada M, Momoi N, Tobita K, et al. (2007) A relationship between vascular endothelial growth factor, angiogenesis, and cardiac repair after muscle stem cell transplantation into ischemic hearts. J Am Coll Cardiol 50: 1677-1684.
66. Roncal C, Buysschaert I, Chorianopoulos E, Georgiadou M, Meilhac O, et al. (2008) Beneficial effects of prolonged systemic administration of PlGF on late outcome of post-ischaemic myocardial performance. J Pathol 216: 236-244.
67. Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, et al. (2003) Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362: 697-703.
68. Elmadbouh I, Haider H, Jiang S, Idris NM, Lu G, et al. (2007) Ex vivo delivered stromal cell-derived factor-1alpha promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium. J Mol Cell Cardiol 42: 792-803.
69. Christov C, Chretien F, Abou-Khalil R, Bassez G, Vallet G, et al. (2007) Muscle satellite cells and endothelial cells: close neighbors and privileged partners. Mol Biol Cell 18: 1397-1409.
70. Williams AH, Valdez G, Moresi V, Qi X, McAnally J, et al. (2009) MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 326: 1549-1554.
71. Menasche P, Alfieri O, Janssens S, McKenna W, Reichenspurner H, et al. (2008) The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 117: 1189-1200.
72. Tapscott SJ, Lassar AB, Davis RL, Weintraub H, (1989) 5-bromo-2'-deoxyuridine blocks myogenesis by extinguishing expression of MyoD1. Science 245: 532-536.
73. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H, (1990) The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 61: 49-59.
74. Rando TA, Blau HM, (1994) Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J Cell Biol 125: 1275-1287.
75. Asakura A, Komaki M, Rudnicki M, (2001) Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation. Differentiation 68: 245-253.
76. Asakura A, Seale P, Girgis-Gabardo A, Rudnicki MA, (2002) Myogenic specification of side population cells in skeletal muscle. J Cell Biol 159: 123-134.
77. Morita S, Kojima TT K, (2000) Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther 7: 1063-1066.
78. Nakamura Y, Yoshiyama M, Omura T, Yoshida K, Kim S, et al. (2002) Transmitral inflow pattern assessed by Doppler echocardiography in angiotensin II type 1A receptor knockout mice with myocardial infarction. Circ J 66: 192-196.
79. Verma M, Asakura Y, Hirai H, Watanabe S, Tastad C, et al. (2010) Flt-1 haploinsufficiency ameliorates muscular dystrophy phenotype by developmentally increased vasculature in mdx mice. Hum Mol Genet 19: 4145-4159.
80. Pyo JO, Nah J, Kim HJ, Chang JW, Song YW, et al. (2008) Protection of cardiomyocytes from ischemic/hypoxic cell death via Drbp1 and pMe2GlyDH in cardio-specific ARC transgenic mice. J Biol Chem 283: 30707-30714.